Quick Overview: Featuring: John Whyte - Chief Medical Officer of WebMD, It's certainly also Larry and it was great to see some friends Laura lazma Betsy green today and to ... discussed by Dr. Jay K. Harness, medical director of BreastCancerAnswers.com, and

Meet Dr Edith Perez Minority - Detailed Overview & Context

Featuring: John Whyte - Chief Medical Officer of WebMD, It's certainly also Larry and it was great to see some friends Laura lazma Betsy green today and to ... discussed by Dr. Jay K. Harness, medical director of BreastCancerAnswers.com, and

Photo Gallery

Meet Dr. Edith Perez | Minority Health Month | Stand Up To Cancer
Dr. Edith Perez on the Antibody-Drug Conjugate T-DM1
Dr. Edith Perez on Adjuvant Treatments
Translational Genomics: The Future is Now | Edith Perez, MD
Dr. Edith Perez Discusses Her Ongoing Research
Dr. Edith Perez Describes the Mayo Clinic Breast Cancer Translational Genomics Program
Dr. Edith Perez on Study 301 That Compared Eribulin to Capecitabine in MBC
Importance of Diverse Participation in Clinical Trials | Stand Up To Cancer
Dr. Edith Perez Discusses the Adjuvant Treatment of Breast Cancer
Dr. Edith Perez Discusses BOLERO-1 Trial Results for HER2-Positive Breast Cancer
Dr. Edith Perez on the development of targeted therapies
Edith A. Perez, MD:  Anti-HER2 Therapies
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored